TrialBlood2022

Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA.

Michele Cavo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.